PortfoliosLab logoPortfoliosLab logo
PROSY vs. NUTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PROSY vs. NUTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Prosus N.V. (PROSY) and Nutex Health Inc (NUTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PROSY achieves a -26.62% return, which is significantly lower than NUTX's -12.28% return.


PROSY

1D
-2.58%
1M
-0.11%
YTD
-26.62%
6M
-27.15%
1Y
-15.15%
3Y*
10.69%
5Y*
-0.56%
10Y*

NUTX

1D
-1.78%
1M
14.33%
YTD
-12.28%
6M
-21.90%
1Y
18.09%
3Y*
31.22%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

PROSY vs. NUTX - Yearly Performance Comparison


2026 (YTD)2025202420232022
PROSY
Prosus N.V.
-26.62%55.67%33.80%-5.32%21.78%
NUTX
Nutex Health Inc
-12.28%419.47%17.37%-90.53%-81.82%

Correlation

The correlation between PROSY and NUTX is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (All Time)
Calculated using the full available price history since Apr 4, 2022

0.15

Fundamentals

EPS

PROSY:

$1.91

NUTX:

$19.08

PE Ratio

PROSY:

4.74

NUTX:

7.57

PEG Ratio

PROSY:

0.03

NUTX:

0.06

PS Ratio

PROSY:

7.94

NUTX:

0.83

Total Revenue (TTM)

PROSY:

$12.76B

NUTX:

$879.95M

Gross Profit (TTM)

PROSY:

$5.31B

NUTX:

$417.67M

EBITDA (TTM)

PROSY:

$10.72B

NUTX:

$275.94M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PROSY vs. NUTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PROSY
PROSY Risk / Return Rank: 2323
Overall Rank
PROSY Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
PROSY Sortino Ratio Rank: 1919
Sortino Ratio Rank
PROSY Omega Ratio Rank: 2020
Omega Ratio Rank
PROSY Calmar Ratio Rank: 2727
Calmar Ratio Rank
PROSY Martin Ratio Rank: 2828
Martin Ratio Rank

NUTX
NUTX Risk / Return Rank: 5151
Overall Rank
NUTX Sharpe Ratio Rank: 4949
Sharpe Ratio Rank
NUTX Sortino Ratio Rank: 5454
Sortino Ratio Rank
NUTX Omega Ratio Rank: 5353
Omega Ratio Rank
NUTX Calmar Ratio Rank: 5050
Calmar Ratio Rank
NUTX Martin Ratio Rank: 4848
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PROSY vs. NUTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Prosus N.V. (PROSY) and Nutex Health Inc (NUTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PROSYNUTXDifference
Sharpe ratioReturn per unit of total volatility

-0.70

Sortino ratioReturn per unit of downside risk

-1.52

Omega ratioGain probability vs. loss probability

0.93

1.11

-0.19

Calmar ratioReturn relative to maximum drawdown

-0.44

0.29

-0.73

Martin ratioReturn relative to average drawdown

-0.81

0.50

-1.32

PROSY vs. NUTX - Sharpe Ratio Comparison

The current PROSY Sharpe Ratio is -0.53, which is lower than the NUTX Sharpe Ratio of 0.17. The chart below compares the historical Sharpe Ratios of PROSY and NUTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PROSY vs. NUTX - Drawdown Comparison

The maximum PROSY drawdown since its inception was -69.36%, smaller than the maximum NUTX drawdown of -99.93%. Use the drawdown chart below to compare losses from any high point for PROSY and NUTX.


Loading charts...

Drawdown Indicators


PROSYNUTXDifference

Max Drawdown

Largest peak-to-trough decline

-69.36%

-99.93%

+30.57%

Max Drawdown (1Y)

Largest decline over 1 year

-39.09%

-54.32%

+15.23%

Max Drawdown (3Y)

Largest decline over 3 years

-39.09%

-94.36%

+55.27%

Max Drawdown (5Y)

Largest decline over 5 years

-60.96%

Current Drawdown

Current decline from peak

-37.79%

-97.59%

+59.80%

Average Drawdown

Average peak-to-trough decline

-30.01%

-97.18%

+67.17%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.26%

30.94%

-9.68%

Volatility

PROSY vs. NUTX - Volatility Comparison

The current volatility for Prosus N.V. (PROSY) is 13.50%, while Nutex Health Inc (NUTX) has a volatility of 17.20%. This indicates that PROSY experiences smaller price fluctuations and is considered to be less risky than NUTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PROSYNUTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.50%

17.20%

-3.70%

Volatility (6M)

Calculated over the trailing 6-month period

27.41%

63.60%

-36.19%

Volatility (1Y)

Calculated over the trailing 1-year period

32.46%

94.82%

-62.36%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

43.10%

191.90%

-148.80%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.64%

191.90%

-150.26%

Dividends

PROSY vs. NUTX - Dividend Comparison

Neither PROSY nor NUTX has paid dividends to shareholders.


PositionTTM202520242023202220212020
NUTX
Nutex Health Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PROSY
Prosus N.V.
0.00%0.00%0.28%0.25%0.20%0.20%0.12%

Financials

PROSY vs. NUTX - Financials Comparison

This section allows you to compare key financial metrics between Prosus N.V. and Nutex Health Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B20222023202420252026
3.64B
216.49M
(PROSY) Total Revenue
(NUTX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


PROSY and NUTX have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NUTX has higher volatility (17.20%) compared to PROSY (13.50%). In terms of maximum drawdown, PROSY dropped -69.36% vs NUTX's -99.93%.

NUTX currently has the higher Sharpe Ratio (0.17 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PROSY and NUTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer